Navigation Links
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
Date:7/8/2010

NEW YORK, July 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment-of-Eye-Care-Medication-Brands.html

This study encompasses feedback provided by U.S. physicians on aspects of ophthalmology drug treatment, enabling interested stakeholders to gain insight into current and future trends. Frost & Sullivan conducted a web-based survey of 152 U.S. Ophthalmologists in November 2009. Of these respondents, 48 percent are in single-specialty group practice, 38 percent are in solo practice, and the rest are in multi-specialty group practice or in hospital-based clinics. 

Please note that Table of Contents numbering has been standardized and may not match numbering within the publication.

1: Research Objectives, Method Details, and Segmentation

1.1: Research Objectives and Method Details

Table 1: Research Objectives and Method Details

1.2: Segmentation

2: Executive Summary

2.1: Patient Compliance to Eye Care Medications

2.2: Factors Impacting Eye Care Medication Prescriptions

2.3: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

Table 2: Ophthalmologists' Preferences and Brand Loyalty When Prescribing Eye Care Medications

3: Patient Compliance with Eye Care Medications

3.1: Assessment of Patient Compliance

3.2: Analyst Comments

3.3: Average Number of Medications Taken by Glaucoma Patients

4: Factors Impacting Prescriptions of Eye Care Medications

4.1: Eye Care Medications: Most Important Features

4.2: Other Factors Correlateda/ with Efficacy, the Most Important Factor for Prescribing Eye Care Medications

4.3: Patients' Involvement in Eye Care Medication Selection Process

5: Preferences for Glaucoma Medications

5.1: Prostaglandin Analogues for Glaucoma

5.1.1: Primary Brand Use and Brand Reputation

5.1.2: Brand Loyalty

5.2: Beta Blockers for Glaucoma

5.2.1: Primary Brand Use and Brand Reputation

5.2.2: Brand Loyalty

5.3: Combination Therapies for Glaucoma

5.3.1: Primary Brand Use and Brand Reputation

5.3.2: Brand Loyalty

5.4: Carbonic Anhydrase Inhibitors for Glaucoma

5.4.1: Primary Brand Use and Brand Reputation

5.4.2: Brand Loyalty

5.5: Alpha Adrenergic Agonists for Glaucoma

5.5.1: Primary Brand Use and Brand Reputation

6: Preferences for Other Eye Disease Medications

6.1: Age-Related Macular Degeneration Medications

6.1.1: Primary Brand Use and Brand Reputation

6.1.2: Brand Loyalty

6.1.3: Lucentis Versus Avastin

6.2: Allergic Conjunctivitis Medications

6.2.1: Primary Brand Use and Brand Reputation

6.2.2: Brand Loyalty

6.3: NSAID Medications

6.3.1: Primary Brand Use and Brand Reputation

6.3.2: Brand Loyalty

7: Appendices

7.1: Preferences for Glaucoma Medications

7.1.1: Prostaglandin Analogues for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.2: Beta Blockers for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.3: Combination Therapies for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.1.4: Carbonic Anhydrase Inhibitors for Glaucoma: Reasons for Top Ranking - Sample of Verbatim Comments

7.2: Preferences for Other Eye Disease Medications

7.2.1: Age-Related Macular Degeneration Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.2: Allergic Conjunctivitis Medications: Reasons for Top Ranking - Sample of Verbatim Comments

7.2.3: NSAID Medications: Reasons for Top Ranking - Sample of Verbatim Comments

To order this report:

Drug and Medication Industry:

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017  GenomeDx Biosciences today announced that six abstracts ... Prostate Cancer Classifier tests will be presented at the ... Congress held March 24 to 28, 2017 in ... is Europe,s largest urological event ... urological field. The abstract titled "Muscle invasive ...
(Date:3/24/2017)... 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today disclosed terms ... Sheet (the "Definitive Financing") it entered into on ... stockholders, who are referred to in the Definitive ... filed with the Securities and Exchange Commission.   ...
(Date:3/23/2017)... based in St. Joseph, Missouri , has selected AccuReg to help ... in 22 cities, and its flagship St. Joseph Medical Center. Mosaic Life ... care to its patients, including the insurance, billing and collections processes. ... ... St. Joseph Medical Center ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of Enea, Scanlan & ... announce Westchester resident Lauren C. Enea has joined the firm as an associate attorney. ... her practice in elder law, Medicaid planning and applications, and Wills, Trusts and Estates. ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion ... to Walk with God #TruthwithGrace” is the creation of published author Lea Michelle ...
(Date:3/23/2017)... Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... emergency and now estimates that there could be four million Zika-related cases in the ... to date with numbers of US cases reported per year skyrocketing to an estimated ...
(Date:3/23/2017)... ... March 23, 2017 , ... PAINWeekEnd (PWE) Oklahoma City, ... Broadway Avenue, will be an educational and exciting program providing busy clinicians and ... of chronic pain. , Oklahoma is in a healthcare crisis. The state ranks ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and thank ... Every day, two kidneys filter about 120 to 150 quarts of blood. Put another ... regulating fluid levels and blood pressure, supporting bone health and promoting red blood cell ...
Breaking Medicine News(10 mins):